InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| A549-Dual™ Cells | Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-De... | 2021 | J Immunol. | Anand G. et al. | DOI: 10.4049/jimmunol.2001407 |
| TLR4 KO Reporter RAW 264.7 Cells | Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-De... | 2021 | J Immunol. | Anand G. et al. | DOI: 10.4049/jimmunol.2001407 |
| IRF3 KO Dual Reporter THP1 Cells | Surface Proteins of SARS-CoV-2 Drive Airway Epithelial Cells to Induce IFN-De... | 2021 | J Immunol. | Anand G. et al. | DOI: 10.4049/jimmunol.2001407 |
| AddaVax™ | Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination. | 2021 | Nat Commun. | Roy D.G. et al. | DOI: 10.1038/s41467-021-22929-z |
| Poly(I:C) (HMW) VacciGrade™ | Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination. | 2021 | Nat Commun. | Roy D.G. et al. | DOI: 10.1038/s41467-021-22929-z |
| Alhydrogel® adjuvant 2% | Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination. | 2021 | Nat Commun. | Roy D.G. et al. | DOI: 10.1038/s41467-021-22929-z |
| Zeocin® | Analysis of Zika virus capsid-Aedes aegypti mosquito interactome reveals pro-... | 2021 | Nat Commun. | Gestuveo R.J. et al. | DOI: 10.1038/s41467-021-22966-8 |
| Blasticidin | Analysis of Zika virus capsid-Aedes aegypti mosquito interactome reveals pro-... | 2021 | Nat Commun. | Gestuveo R.J. et al. | DOI: 10.1038/s41467-021-22966-8 |
| Pam3CSK4 | Transcriptional signature in microglia associated with Aβ plaque phagocytosis. | 2021 | Nat Commun. | Grubman A. et al. | DOI: 10.1038/s41467-021-23111-1 |
| Poly(I:C) HMW | Transcriptional signature in microglia associated with Aβ plaque phagocytosis. | 2021 | Nat Commun. | Grubman A. et al. | DOI: 10.1038/s41467-021-23111-1 |
| DMXAA | TNF controls a speed-accuracy tradeoff in the cell death decision to restrict... | 2021 | Nat Commun. | Oyler-Yaniv J. et al. | DOI: 10.1038/s41467-021-23195-9 |
| LPS-EK (LPS from E. coli K12) | TNF controls a speed-accuracy tradeoff in the cell death decision to restrict... | 2021 | Nat Commun. | Oyler-Yaniv J. et al. | DOI: 10.1038/s41467-021-23195-9 |
| Pam3CSK4 VacciGrade™ | The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it f... | 2021 | Nat Commun. | Vijayaraj S.L. et al. | DOI: 10.1038/s41467-021-22979-3 |
| LPS-EB VacciGrade™ | The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it f... | 2021 | Nat Commun. | Vijayaraj S.L. et al. | DOI: 10.1038/s41467-021-22979-3 |
| IL-4 & IL-13 Reporter HEK 293 Cells | Dual vaccination against IL-4 and IL-13 protects against chronic allergic ast... | 2021 | Nat Commun. | Conde E. et al. | DOI: 10.1038/s41467-021-22834-5 |
| QUANTI-Blue™ | Dual vaccination against IL-4 and IL-13 protects against chronic allergic ast... | 2021 | Nat Commun. | Conde E. et al. | DOI: 10.1038/s41467-021-22834-5 |
| Alhydrogel® adjuvant 2% | Dual vaccination against IL-4 and IL-13 protects against chronic allergic ast... | 2021 | Nat Commun. | Conde E. et al. | DOI: 10.1038/s41467-021-22834-5 |
| IL-2 & IL-15 Reporter HEK 293 Cells | A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrati... | 2021 | Nat Commun. | Hsu E.J. et al. | DOI: 10.1038/s41467-021-22980-w |
| QUANTI-Blue™ | A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrati... | 2021 | Nat Commun. | Hsu E.J. et al. | DOI: 10.1038/s41467-021-22980-w |
| Poly(dA:dT) | The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. | 2021 | Nature | Fidler T.P. et al. | DOI: 10.1038/s41586-021-03341-5 |